Loading…

The effect of transdermal 17- β-estradiol on glucose metabolism of postmenopausal women is evident during the oral but not the intravenous glucose administration

Objectives: To evaluate the effect of transdermal 17- β-estradiol (50 μg/day) on glucose metabolism of postmenopausal women. Study design: A frequently sampled intravenous glucose tolerance test (FSIGT), to calculate insulin sensitivity ( S I) and peripheral glucose utilization independent of insuli...

Full description

Saved in:
Bibliographic Details
Published in:Maturitas 1997-12, Vol.28 (2), p.163-167
Main Authors: Cagnacci, Angelo, Tuveri, Federica, Cirillo, Rocco, Setteneri, Anna Maria, Melis, Gian Benedetto, Volpe, Annibale
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objectives: To evaluate the effect of transdermal 17- β-estradiol (50 μg/day) on glucose metabolism of postmenopausal women. Study design: A frequently sampled intravenous glucose tolerance test (FSIGT), to calculate insulin sensitivity ( S I) and peripheral glucose utilization independent of insulin ( S G), and an oral glucose tolerance test (75 g; OGTT), were performed in nine postmenopausal women prior to, and after 2 months of, treatment. Results: Estradiol decreased insulin and increased the C-peptide/insulin ratio both during fasting ( P
ISSN:0378-5122
1873-4111
DOI:10.1016/S0378-5122(97)00064-9